Intellectual Property (IP), Artificial Intelligence (AI), Open Movements (OM)

My Bloomsbury book "Ethics, Information, and Technology" was published on Nov. 13, 2025. Purchases can be made via Amazon and this Bloomsbury webpage: https://www.bloomsbury.com/us/ethics-information-and-technology-9781440856662/

Showing posts with label Big Pharma pricing. Show all posts

Saturday, November 22, 2025

Eli Lilly Reaches $1 Trillion in Value, Buoyed by Demand for Its Weight Loss Drugs; The New York Times, November 21, 2025

›

Rebecca Robbins , The New York Times; Eli Lilly Reaches $1 Trillion in Value, Buoyed by Demand for Its Weight Loss Drugs " Pharmace...

Tuesday, July 29, 2025

Tariffs on Medicines From Europe Stand to Cost Drugmakers Billions; The New York Times, July 28, 2025

›

Rebecca Robbins , The New York Times; Tariffs on Medicines From Europe Stand to Cost Drugmakers Billions " The trade deal reached bet...

Tuesday, July 18, 2017

Escaping Big Pharma’s Pricing With Patent-Free Drugs; New York Times, July 18, 2017

›

Fran Quigley, New York Times; Escaping Big Pharma’s Pricing With Patent-Free Drugs " Although President Trump said before taking off...

›

Home

View web version

About Me

Kip Currier, PhD, JD: Assistant Professor, University of Pittsburgh School of Computing and Information. Education: PhD, University of Pittsburgh School of Information Sciences (2007); Juris Doctor (JD), University of Pittsburgh School of Law; Master of Library and Information Science (MLIS), University of Pittsburgh School of Information Sciences. Member of American Bar Association (ABA), ABA IP Law Section, ABA Science & Technology Section

View my complete profile